These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 25904541)

  • 1. Enhanced Classification of Brugada Syndrome-Associated and Long-QT Syndrome-Associated Genetic Variants in the SCN5A-Encoded Na(v)1.5 Cardiac Sodium Channel.
    Kapplinger JD; Giudicessi JR; Ye D; Tester DJ; Callis TE; Valdivia CR; Makielski JC; Wilde AA; Ackerman MJ
    Circ Cardiovasc Genet; 2015 Aug; 8(4):582-95. PubMed ID: 25904541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phylogenetic and physicochemical analyses enhance the classification of rare nonsynonymous single nucleotide variants in type 1 and 2 long-QT syndrome.
    Giudicessi JR; Kapplinger JD; Tester DJ; Alders M; Salisbury BA; Wilde AA; Ackerman MJ
    Circ Cardiovasc Genet; 2012 Oct; 5(5):519-28. PubMed ID: 22949429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further Insights in the Most Common SCN5A Mutation Causing Overlapping Phenotype of Long QT Syndrome, Brugada Syndrome, and Conduction Defect.
    Veltmann C; Barajas-Martinez H; Wolpert C; Borggrefe M; Schimpf R; Pfeiffer R; Cáceres G; Burashnikov E; Antzelevitch C; Hu D
    J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27381756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long QT and Brugada syndrome gene mutations in New Zealand.
    Chung SK; MacCormick JM; McCulley CH; Crawford J; Eddy CA; Mitchell EA; Shelling AN; French JK; Skinner JR; Rees MI
    Heart Rhythm; 2007 Oct; 4(10):1306-14. PubMed ID: 17905336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the predictive accuracy of five in silico prediction tools, alone or in combination, and two metaservers to classify long QT syndrome gene mutations.
    Leong IU; Stuckey A; Lai D; Skinner JR; Love DR
    BMC Med Genet; 2015 May; 16():34. PubMed ID: 25967940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic testing for long-QT syndrome: distinguishing pathogenic mutations from benign variants.
    Kapa S; Tester DJ; Salisbury BA; Harris-Kerr C; Pungliya MS; Alders M; Wilde AA; Ackerman MJ
    Circulation; 2009 Nov; 120(18):1752-60. PubMed ID: 19841300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brugada syndrome: clinical presentation and genotype-correlation with magnetic resonance imaging parameters.
    Rudic B; Schimpf R; Veltmann C; Doesch C; Tülümen E; Schoenberg SO; Borggrefe M; Papavassiliu T
    Europace; 2016 Sep; 18(9):1411-9. PubMed ID: 26511399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A sodium channel pore mutation causing Brugada syndrome.
    Pfahnl AE; Viswanathan PC; Weiss R; Shang LL; Sanyal S; Shusterman V; Kornblit C; London B; Dudley SC
    Heart Rhythm; 2007 Jan; 4(1):46-53. PubMed ID: 17198989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of long QT syndrome-associated SCN5A variants in patients with early-onset lone atrial fibrillation.
    Olesen MS; Yuan L; Liang B; Holst AG; Nielsen N; Nielsen JB; Hedley PL; Christiansen M; Olesen SP; Haunsø S; Schmitt N; Jespersen T; Svendsen JH
    Circ Cardiovasc Genet; 2012 Aug; 5(4):450-9. PubMed ID: 22685113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Spectrum of SCN5A Mutations: Long QT Syndrome, Brugada Syndrome, and Cardiomyopathy.
    Wilde AAM; Amin AS
    JACC Clin Electrophysiol; 2018 May; 4(5):569-579. PubMed ID: 29798782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complex interactions in a novel SCN5A compound mutation associated with long QT and Brugada syndrome: Implications for Na+ channel blocking pharmacotherapy for de novo conduction disease.
    Liu J; Bayer JD; Aschar-Sobbi R; Wauchop M; Spears D; Gollob M; Vigmond EJ; Tsushima R; Backx PH; Chauhan VS
    PLoS One; 2018; 13(5):e0197273. PubMed ID: 29791480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilsicainide Administration Unmasks a Phenotype of Brugada Syndrome in a Patient with Overlap Syndrome due to the E1784K SCN5A Mutation.
    Hasebe H; Yokoya T; Murakoshi N; Kurebayashi N
    Intern Med; 2020 Jan; 59(1):83-87. PubMed ID: 31484910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic re-evaluation of SCN5A variants associated with Brugada syndrome.
    Denham NC; Pearman CM; Ding WY; Waktare J; Gupta D; Snowdon R; Hall M; Cooper R; Modi S; Todd D; Mahida S
    J Cardiovasc Electrophysiol; 2019 Jan; 30(1):118-127. PubMed ID: 30203441
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Kroncke BM; Glazer AM; Smith DK; Blume JD; Roden DM
    Circ Genom Precis Med; 2018 May; 11(5):e002095. PubMed ID: 29728395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic ajmaline challenge in patients with long QT 3 syndrome caused by the most common mutation: a multicentre study.
    Hohmann S; Rudic B; Konrad T; Duncker D; König T; Tülümen E; Rostock T; Borggrefe M; Veltmann C
    Europace; 2017 Oct; 19(10):1723-1729. PubMed ID: 27915266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectrum and prevalence of cardiac sodium channel variants among black, white, Asian, and Hispanic individuals: implications for arrhythmogenic susceptibility and Brugada/long QT syndrome genetic testing.
    Ackerman MJ; Splawski I; Makielski JC; Tester DJ; Will ML; Timothy KW; Keating MT; Jones G; Chadha M; Burrow CR; Stephens JC; Xu C; Judson R; Curran ME
    Heart Rhythm; 2004 Nov; 1(5):600-7. PubMed ID: 15851227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sinus node dysfunction, Brugada syndrome and long QT syndrome affecting the same patient : when genetics can't make head or tail of it].
    Porretta AP; Davoine E; Superti-Furga A; Bhuiyan ZA; Domenichini G; Herrera Siklody C; Pascale P; Haddad C; Schläpfer J; Pruvot É
    Rev Med Suisse; 2020 Jun; 16(696):1148-1152. PubMed ID: 32496703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multisite Validation of a Functional Assay to Adjudicate
    Ma JG; O'Neill MJ; Richardson E; Thomson KL; Ingles J; Muhammad A; Solus JF; Davogustto G; Anderson KC; Shoemaker MB; Stergachis AB; Floyd BJ; Dunn K; Parikh VN; Chubb H; Perrin MJ; Roden DM; Vandenberg JI; Ng CA; Glazer AM
    Circ Genom Precis Med; 2024 Aug; 17(4):e004569. PubMed ID: 38953211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Clinical Manifestation of the Known SCN5A D1790G Mutation.
    Blich M; Efrati E; Marai I; Suleiman M; Gepstein L; Boulous M
    Cardiology; 2015; 132(4):228-32. PubMed ID: 26304620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation Load of Multiple Ion Channel Gene Mutations in Brugada Syndrome.
    Gualandi F; Zaraket F; Malagù M; Parmeggiani G; Trabanelli C; Fini S; Dang X; Wei X; Fang M; Bertini M; Ferrari R; Ferlini A
    Cardiology; 2017; 137(4):256-260. PubMed ID: 28494446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.